Medevise Headed to Milan’s Three Biggest Ophthalmology Meetings
Medevise Headed to Milan’s Three Biggest Ophthalmology Meetings – Ophthalmology Futures Forum, iNovation and the ESCRS Congress
A new name with very familiar faces – the Medevise team has decades of experience in ophthalmology working across all aspects of the industry. We arrive in Milan eager to take on partners who share our objective of delivering the top ophthalmic innovations to patients across Europe.
15 September 2022
Ophthalmology Futures Forum
Medevise is a sponsor of the event and Bruce Gould, our Chief Business Officer, will be on stage to do a company presentation at 14:40 CET.
16 September 2022
iNovation Day
Dedicated to bringing innovation to ophthalmology in Europe, we are a proud sponsor of the ESCRS iNovation Day and we will also have Medevise leaders, Kristine Morrill and Michael Mrochen, on stage as part of the Session #5 panel, “Funding Innovation in Europe,” at 12:40 CET.
Lead by Mr Paul Rosen, there will be a presentation of the European market, IPOs and investment trends followed by discussion on:
· Financing small companies in Europe
· Investing in emerging European companies
· Launching products in Europe
· Key financial trends that may change this landscape.
17-19 September 2022
ESCRS Congress
Medevise will be supporting multiple clients in their initiatives at this very important Congress in addition to having our own booth in Hall B #2W36 offering complimentary initial consultations on Market Access, Clinical & Regulatory and Marketing & Medical Communications which can be booked in advance here.
Separately, President & Founder Kristine Morrill, who has been consulting on the ESCRS Practice Management Program since it’s inception, will be on podium discussing the topic with other leaders in the space on Sunday, 18 September and Monday, 19 September. To hear more about this event, check out our latest Business of Eye Innovation Podcast episode with program creators Mr Paul Rosen and Colin Kerr.
To learn more about Medevise, connect with us on LinkedIn.